• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF.因心力衰竭住院患者的健康状况临床病程及其与预后的关联:ASCEND-HF研究的见解
Eur J Heart Fail. 2016 Mar;18(3):306-13. doi: 10.1002/ejhf.420. Epub 2015 Oct 14.
2
Aerobic exercise training and general health status in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)trial.射血分数降低的门诊心力衰竭患者的有氧运动训练与总体健康状况——心力衰竭与运动训练结局对照试验(HF-ACTION)的研究结果
Am Heart J. 2017 Apr;186:130-138. doi: 10.1016/j.ahj.2016.12.017. Epub 2017 Jan 19.
3
Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction).心肌梗死后心血管事件对患者生活质量和效用变化的影响:VALIANT 研究(缬沙坦急性心肌梗死)。
JACC Heart Fail. 2014 Apr;2(2):159-65. doi: 10.1016/j.jchf.2013.12.003.
4
Health-related quality of life is an independent predictor of mortality and hospitalisations in transthyretin amyloid cardiomyopathy: a prospective cohort study.健康相关生活质量是转甲状腺素淀粉样变心肌病患者死亡率和住院率的独立预测因素:一项前瞻性队列研究。
Qual Life Res. 2024 Oct;33(10):2743-2753. doi: 10.1007/s11136-024-03723-y. Epub 2024 Aug 6.
5
EuroQol (EQ-5D) measure of quality of life predicts mortality, emergency department utilization, and hospital discharge rates in HIV-infected adults under care.欧洲五维度健康量表(EQ-5D)对生活质量的衡量能够预测接受治疗的HIV感染成年人的死亡率、急诊就诊率及出院率。
Health Qual Life Outcomes. 2007 Jan 25;5:5. doi: 10.1186/1477-7525-5-5.
6
Liver function tests in patients with acute heart failure and associated outcomes: insights from ASCEND-HF.急性心力衰竭患者的肝功能检查及其相关结局:来自 ASCEND-HF 的观察。
Eur J Heart Fail. 2016 Apr;18(4):424-32. doi: 10.1002/ejhf.440. Epub 2015 Dec 28.
7
Sex Differences in Clinical Course and Patient-Reported Outcomes Among Patients Hospitalized for Heart Failure.心力衰竭住院患者的临床病程和患者报告结局的性别差异。
JACC Heart Fail. 2021 May;9(5):336-345. doi: 10.1016/j.jchf.2020.12.011. Epub 2021 Mar 10.
8
Comparing New York Heart Association Class and Patient-Reported Outcomes Among Patients Hospitalized for Heart Failure.比较因心力衰竭住院患者的纽约心脏协会分级与患者报告的结局。
Circ Heart Fail. 2023 Jan;16(1):e010107. doi: 10.1161/CIRCHEARTFAILURE.122.010107. Epub 2022 Oct 31.
9
Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial.急性心力衰竭住院期间及出院后的体重变化:患者特征、充血标志物及预后:ASCEND-HF试验的结果
JACC Heart Fail. 2017 Jan;5(1):1-13. doi: 10.1016/j.jchf.2016.09.012.
10
Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF).急性心力衰竭住院期间及出院后充血症状的缓解与复发:急性失代偿性心力衰竭利尿优化策略评估(DOSE-AHF)及急性失代偿性心力衰竭心肾挽救研究(CARESS-HF)的见解
Circ Heart Fail. 2015 Jul;8(4):741-8. doi: 10.1161/CIRCHEARTFAILURE.114.001957. Epub 2015 Jun 3.

引用本文的文献

1
Effects of traditional Chinese exercises on the rehabilitation of patients with chronic heart failure: A -analysis.中医传统运动对慢性心力衰竭患者康复的影响:一项荟萃分析。
Int J Cardiol Heart Vasc. 2025 Aug 20;60:101778. doi: 10.1016/j.ijcha.2025.101778. eCollection 2025 Oct.
2
Quality of life post heart failure diagnosis: population-level trends in the U.S.心力衰竭诊断后的生活质量:美国的人群水平趋势
Health Qual Life Outcomes. 2025 May 30;23(1):53. doi: 10.1186/s12955-025-02372-0.
3
Cost-Utility and Budget Impact Analysis of Adding SGLT-2 Inhibitors to Standard Treatment in Type 2 Diabetes Patients with Heart Failure: Utilizing National Database Insights from Thailand.在2型糖尿病合并心力衰竭患者的标准治疗中添加钠-葡萄糖协同转运蛋白2(SGLT-2)抑制剂的成本-效用和预算影响分析:利用泰国的国家数据库见解
Pharmacoecon Open. 2025 Jan;9(1):69-81. doi: 10.1007/s41669-024-00526-2. Epub 2024 Sep 22.
4
Cost-effectiveness of eculizumab and efgartigimod for the treatment of anti-acetylcholine receptor antibody-positive generalized myasthenia gravis.依库珠单抗和依氟鸟氨酸治疗抗乙酰胆碱受体抗体阳性全身型重症肌无力的成本效果分析。
J Manag Care Spec Pharm. 2024 Jun;30(6):517-527. doi: 10.18553/jmcp.2024.30.6.517.
5
The association in diabetic retinopathy and stroke finding from NHANES evidence.NHANES 证据表明糖尿病视网膜病变与中风之间的关联。
Int Ophthalmol. 2024 Apr 8;44(1):170. doi: 10.1007/s10792-024-03098-6.
6
Neighborhood Socioeconomic Disadvantage and Hospitalized Heart Failure Outcomes in the American Heart Association Get With The Guidelines-Heart Failure Registry.美国心脏协会 Get With The Guidelines-Heart Failure 注册研究中的社区社会经济劣势与心力衰竭住院结局
Circ Heart Fail. 2022 Nov;15(11):e009353. doi: 10.1161/CIRCHEARTFAILURE.121.009353. Epub 2022 Nov 15.
7
In-Hospital Virtual Peer-to-Peer Consultation to Increase Guideline-Directed Medical Therapy for Heart Failure: A Pilot Randomized Trial.院内虚拟同行间咨询以增加心力衰竭的指南导向药物治疗:一项试点随机试验。
Circ Heart Fail. 2023 Feb;16(2):e010158. doi: 10.1161/CIRCHEARTFAILURE.122.010158. Epub 2022 Oct 31.
8
A Proposal of a Cost-Effectiveness Modeling Approach for Heart Failure Treatment Assessment: Considering the Short- and Long-Term Impact of Hospitalization on Event Rates.心力衰竭治疗评估的成本效益建模方法提案:考虑住院对事件发生率的短期和长期影响。
Pharmacoeconomics. 2022 Nov;40(11):1095-1105. doi: 10.1007/s40273-022-01174-2. Epub 2022 Aug 12.
9
Quality of Life in Older Patients after a Heart Failure Hospitalization: Results from the SENECOR Study.心力衰竭住院老年患者的生活质量:SENECOR研究结果
J Clin Med. 2022 May 27;11(11):3035. doi: 10.3390/jcm11113035.
10
Financial Incentives for Transcatheter Aortic Valve Implantation in Ontario, Canada: A Cost-Utility Analysis.加拿大安大略省经导管主动脉瓣植入术的经济激励措施:成本-效用分析。
J Am Heart Assoc. 2022 Apr 19;11(8):e025085. doi: 10.1161/JAHA.121.025085. Epub 2022 Apr 12.

本文引用的文献

1
International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction.心力衰竭伴射血分数保留和降低的临床试验中事件发生率的国际地域差异。
Circulation. 2015 Jan 6;131(1):43-53. doi: 10.1161/CIRCULATIONAHA.114.012284. Epub 2014 Nov 18.
2
Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial.TOPCAT 试验中醛固酮拮抗剂治疗心脏收缩功能保留心力衰竭患者及结局的地域差异。
Circulation. 2015 Jan 6;131(1):34-42. doi: 10.1161/CIRCULATIONAHA.114.013255. Epub 2014 Nov 18.
3
Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction).心肌梗死后心血管事件对患者生活质量和效用变化的影响:VALIANT 研究(缬沙坦急性心肌梗死)。
JACC Heart Fail. 2014 Apr;2(2):159-65. doi: 10.1016/j.jchf.2013.12.003.
4
Differences in treatment, outcomes, and quality of life among patients with heart failure in Canada and the United States.加拿大和美国心力衰竭患者的治疗、结局和生活质量差异。
JACC Heart Fail. 2013 Dec;1(6):523-30. doi: 10.1016/j.jchf.2013.07.004. Epub 2013 Oct 23.
5
The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.心力衰竭住院患者的全球健康和经济负担:从心力衰竭住院登记中吸取的经验教训。
J Am Coll Cardiol. 2014 Apr 1;63(12):1123-1133. doi: 10.1016/j.jacc.2013.11.053. Epub 2014 Feb 5.
6
Heart disease and stroke statistics--2014 update: a report from the American Heart Association.《2014年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2014 Jan 21;129(3):e28-e292. doi: 10.1161/01.cir.0000441139.02102.80. Epub 2013 Dec 18.
7
Quality of life assessment for acute heart failure patients from emergency department presentation through 30 days after discharge: a pilot study with the Kansas City Cardiomyopathy Questionnaire.从急诊科就诊到出院后 30 天的急性心力衰竭患者生活质量评估:一项采用堪萨斯心肌病问卷的初步研究。
J Card Fail. 2014 Jan;20(1):18-22. doi: 10.1016/j.cardfail.2013.11.010. Epub 2013 Dec 1.
8
Need for increased awareness and evidence-based therapies for patients hospitalized for heart failure.需要提高对因心力衰竭住院患者的认识并采用循证疗法。
JAMA. 2013 Nov 20;310(19):2035-6. doi: 10.1001/jama.2013.282815.
9
Determinants of quality of life of patients with heart failure and iron deficiency treated with ferric carboxymaltose: FAIR-HF sub-analysis.用羧基麦芽糖铁治疗的心力衰竭合并缺铁患者生活质量的决定因素:FAIR-HF亚组分析
Int J Cardiol. 2013 Oct 9;168(4):3878-83. doi: 10.1016/j.ijcard.2013.06.045. Epub 2013 Jul 17.
10
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会基金会/美国心脏协会实践指南工作组关于心力衰竭管理的指南:美国心脏病学会基金会/美国心脏协会报告
J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239. doi: 10.1016/j.jacc.2013.05.019. Epub 2013 Jun 5.

因心力衰竭住院患者的健康状况临床病程及其与预后的关联:ASCEND-HF研究的见解

The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF.

作者信息

Ambrosy Andrew P, Hernandez Adrian F, Armstrong Paul W, Butler Javed, Dunning Allison, Ezekowitz Justin A, Felker G Michael, Greene Stephen J, Kaul Padma, McMurray John J, Metra Marco, O'Connor Christopher M, Reed Shelby D, Schulte Phillip J, Starling Randall C, Tang W H Wilson, Voors Adriaan A, Mentz Robert J

机构信息

Duke University Medical Center, Durham, NC, USA.

Duke Clinical Research Institute, Durham, NC, USA.

出版信息

Eur J Heart Fail. 2016 Mar;18(3):306-13. doi: 10.1002/ejhf.420. Epub 2015 Oct 14.

DOI:10.1002/ejhf.420
PMID:26467269
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4801656/
Abstract

AIMS

A longitudinal and comprehensive analysis of health-related quality of life (HRQOL) was performed during hospitalization for heart failure (HF) or soon after discharge.

METHODS AND RESULTS

A post-hoc analysis was performed of the ASCEND-HF trial. The EuroQOL five dimensions questionnaire (EQ-5D) was administered to study participants at baseline, 24 h, discharge/day 10, and day 30. EQ-5D includes functional dimensions mapped to corresponding utility scores (i.e. 0 = death and 1 = perfect health), and a visual analogue scale (VAS) ranging from 0 (i.e. 'worst imaginable health state') to 100 (i.e. 'best imaginable health state'). The association between baseline and discharge EQ-5D measurements and subsequent clinical outcomes including death and rehospitalization were assessed using multivariable logistic regression and Cox proportional hazards regression. A total of 6943 patients (97%) had complete EQ-5D data at baseline. Mapped utility and VAS scores (mean ± SD) increased over time, respectively, from 0.56 ± 0.23 and 45 ± 22 at baseline to 0.67 ± 0.26 and 58 ± 22 at 24 h and to 0.79 ± 0.20 and 68 ± 22 at discharge, and remained stable at day 30. Lower mapped utility scores at baseline [odds ratio (OR) per 0.1 decrease in utility score 1.03, 95% confidence interval (CI) 1.00-1.06] and discharge (OR 1.10, 95% CI 1.05-1.15) and VAS scores at baseline (OR per 10 point decrease 1.05, 95% CI 1.01-1.09) were significantly associated with increased risk of 30-day all-cause death or HF rehospitalization.

CONCLUSIONS

Patients hospitalized for HF had severely impaired health status at baseline and, although this improved substantially during admission, health status remained abnormal at discharge.

摘要

目的

在心力衰竭(HF)住院期间或出院后不久,对健康相关生活质量(HRQOL)进行纵向和全面分析。

方法与结果

对ASCEND-HF试验进行事后分析。在基线、24小时、出院/第10天和第30天,对研究参与者进行欧洲五维健康量表(EQ-5D)评估。EQ-5D包括映射到相应效用分数的功能维度(即0 = 死亡,1 = 完美健康),以及一个从0(即“可想象到的最差健康状态”)到100(即“可想象到的最佳健康状态”)的视觉模拟量表(VAS)。使用多变量逻辑回归和Cox比例风险回归评估基线和出院时EQ-5D测量值与随后包括死亡和再住院在内的临床结局之间的关联。共有6943名患者(97%)在基线时有完整的EQ-5D数据。映射的效用和VAS分数(均值±标准差)随时间增加,分别从基线时的0.56±0.23和45±22增加到24小时时的0.67±0.26和58±22,出院时为0.79±0.20和68±22,并在第30天保持稳定。基线时较低的映射效用分数[效用分数每降低0.1的比值比(OR)为1.03,95%置信区间(CI)为1.00 - 1.06]和出院时(OR为1.10,95% CI为1.05 - 1.15)以及基线时的VAS分数(每降低10分的OR为1.05,95% CI为1.01 - 1.09)与30天全因死亡或HF再住院风险增加显著相关。

结论

因HF住院的患者在基线时健康状况严重受损,尽管在住院期间有显著改善,但出院时健康状况仍不正常。